Xiangmin Xu
Works at
Sources: reporter.nih.gov
Grants and prizes
U01, Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease, U01AG076791, 2022–2027, 5 May 2026
R01, Cell-type-specific and spatial proteogenomics analysis of aberrant RNA splicing and misfolded proteins in Alzheimer's related tauopathies, R01AG092453, 2025–2030, 10 Mar 2026
R01, Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions, R01AG082127, 2023–2028, 29 Jan 2026
R61, Enhancer AAV-based genetic access and manipulation of specific brain cell types implicated in aging and Alzheimer's Disease, R61AG094609, 2025–2027, 22 Aug 2025
National Institute on Drug Abuse
U01, Single-Cell Analysis of Aging-Associated 4D Nucleome in the Human Hippocampus, U01DA052769, 2020–2025, 21 Aug 2024
R01, Neural circuit mechanisms underlying AD-related memory impairments, R01AG065675, 2020–2026, 1 Aug 2024
R24, Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models, R24AG073198, 2021–2025, 9 Jul 2024
R01, Epigenomic analysis of neural circuits in Alzheimer's disease mouse models, R01AG067153, 2020–2025, 25 Apr 2024
Sources: reporter.nih.gov